Amy E. Schade
Impact in
-
- Cancer-related Molecular Pathways
-
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Ubiquitin and proteasome pathways
- Genomics and Chromatin Dynamics
- FOXO transcription factor regulation
Papers in
- Oncology 5
- Cancer-related Molecular Pathways 3
-
- Ubiquitin and proteasome pathways 3
- FOXO transcription factor regulation 2
- Epigenetics and DNA Methylation 2
- Photosynthetic Processes and Mechanisms 1
- RNA modifications and cancer 1
- Co-authors
- James A. DeCaprio (5 shared papers)Martin Fischer (3 shared papers)Timothy B. Branigan (2 shared papers)Gerd A. Müller (1 shared paper)Matthew G. Oser (1 shared paper)Hilary Elaine Nicholson (1 shared paper)Karen Cichowski (2 shared papers)Mi‐Ju Kim (1 shared paper)
- Journals
- Trends in Biochemical Sciences (2 papers)Cancer Discovery (1 paper)PLoS Biology (1 paper)Nucleic Acids Research (1 paper)eLife (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Amy E. Schade
10 papers receiving 440 citations
Peers
Comparison fields: 5 of 72
- Oncology 129
- Molecular Biology 290
- Cell Biology 67
- Cancer Research 46
- Aging 6
Countries citing papers authored by Amy E. Schade
This map shows the geographic impact of Amy E. Schade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E. Schade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E. Schade more than expected).
Fields of papers citing papers by Amy E. Schade
This network shows the impact of papers produced by Amy E. Schade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E. Schade. The network helps show where Amy E. Schade may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy E. Schade, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 158 | |
| 2 | 2019 | 65 | |
| 3 | 2019 | 55 | |
| 4 | 2020 | 45 | |
| 5 | 2024 | 39 | |
| 6 | 2021 | 34 | |
| 7 | 2023 | 19 | |
| 8 | 2023 | 14 | |
| 9 | 2024 | 9 | |
| 10 | 2004 | 6 | |
| 11 | 2023 | 0 |
About Amy E. Schade
Amy E. Schade is a scholar working on Oncology, Molecular Biology, Cancer Research, Small Animals and Biotechnology, having authored 11 papers that have together received 444 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (3 papers), Ubiquitin and proteasome pathways (3 papers), FOXO transcription factor regulation (2 papers), Epigenetics and DNA Methylation (2 papers), MicroRNA in disease regulation (1 paper), Cancer Genomics and Diagnostics (1 paper), Photosynthetic Processes and Mechanisms (1 paper) and RNA modifications and cancer (1 paper). The work is most often cited by research in Oncology (129 citations), Molecular Biology (290 citations), Cell Biology (67 citations), Cancer Research (46 citations) and Aging (6 citations). Amy E. Schade has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include James A. DeCaprio, Martin Fischer, Timothy B. Branigan, Gerd A. Müller, Matthew G. Oser, Hilary Elaine Nicholson, Karen Cichowski, Mi‐Ju Kim, Laurence A. Florens and David Kozono. Their work appears in journals such as Trends in Biochemical Sciences, Cancer Discovery, PLoS Biology, Nucleic Acids Research and eLife.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.